Company intelligence / Profile preview

Hefei Tianhui Industry Technology

Hefei, Anhui, China

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Oral insulin capsule has completed Phase IIb in USA and Phase III in China; NDA submitted to NMPA in China. Planning new Phase 3 in US with revised protocol.

Therapeutic areas: Endocrinology
Modalities: Recombinant proteinHormone
Industry: Biotech

Partnerships

Oramed Pharmaceuticals Inc.OraTech Pharmaceuticals (joint venture)

Beyond the preview

Go deeper on Hefei Tianhui Industry Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hefei Tianhui Industry Technology.

Explore the full profile